Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C

Gut

Volumn 56, Issue 5, 2007, Pages 693-698

  Sartori, Massimo ^a   Andorno, Silvano ^a   Pagliarulo, Michela ^a   Rigamonti, Cristina ^b   Bozzola, Cristina ^b   Pergolini, Patrizia ^a   Rolla, Roberta ^b   Suno, Anna ^a   Boldorini, Renzo ^b   Bellomo, Giorgio ^b   Albano, Emanuele ^b  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; FERROPORTIN 1; HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IRON;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HEMOCHROMATOSIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOBINS; HEMOCHROMATOSIS; HEPATITIS C, CHRONIC; HETEROZYGOTE; HUMANS; IRON; IRON OVERLOAD; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 34247498123     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.106641     Document Type: Article

References (35)

1. Patel K, Muir AJ, McHutchison JG. Diagnosis and treatment of chronic hepatitis C infection. BMJ 2006;332:1013-17.
2. Feld JJ, Liang TJ. Hepatitis C - identifying patients with progressive liver injury. Hepatology 2006;43:S194-206.
3. Massard J, Ratziu V, Thabut D, et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 2006;44:S19-24.
4. Eisenbach C, Gehrke SG, Stremmel W. Iron, the HFE gene, and hepatitis C. Clin Liver Dis 2004;8:775-85.
5. Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis 2005;25:461-72.
6. Beutler E. Hemochromatosis: genetics and pathophysiology. Annu Rev Med 2006;57:331-47.
7. Pietrangelo A. Hemochromatosis gene modifies course of hepatitis C viral infection. Gastroenterology 2003;124:1509-23.
8. Deicher R, Hörl WH. New insights into the regulation of iron homeostasis. Eur J Clin Invest 2006;36:301-9.
9. Pietrangelo A. Molecular insights into the pathogenesis of hereditary haemocnromatosis. Gut 2006;55:564-8.
10. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann NY Acad Sci 1997;336:1298-301.
11. Vento S, Caianello F, Cesario F. Infection and thalassemia. Lancet Infect Dis 2006;6:226-33.
12. Sartori M, Andorno S, La Terra G, et al. Evaluation of iron status in patients with chronic hepatitis C. Ital J Gastroenterol Hepatol 1998;30:396-401.
13. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
14. Searle JW, Kerr JFR, Halliday JW, et al. Iron storage diseases. In: MacSween RNM, Antony PP, Scheuer PJ, eds. Pathology of the liver, 2nd edn. Edinburgh: Churchill Livingston, 1987.
15. Di Bisceglie AM, Axiotis CA, Hoffnagle JH, et al. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-13.
16. Sartori M, Andorno S, Rigamonti C, et al. Chronic hepatitis C is mild in menstruating women. J Gastroenterol Hepatol 2000;15:1411-17.
17. Theurl I, Zoller H, Obrist P, et al. Iron regulates hepatitis C virus translation via stimulation of expression of translation initiator factor 3. J Infect Dis 2004;190:819-25.
18. Fillebeen C, Rivas-Estilla AM, Bisaillon M, et al. Iron inactivates the RNA polymerase NS5B and suppress subgenomic replication of hepatitis C virus. J Biol Chem 2005;280:9049-57.
19. Choi J, Ou JH. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol 2006;290:G847-51.
20. Furutani T, Hino K, Okuda M, et al. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 2006;130:2087-98.
21. Ganz T, Nemeth E. Iron Imports. IV. Hepcidin and the regulation of body iron metabolism. Am J Physiol 2006;290:G199-203.
22. Aoki CA, Rossaro L, Ramsamooj R, et al. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. J Clin Gastroenterol 2005;39:71-4.
23. Tung BY, Edmond MJ, Bronner MP, et al. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 2003;124:318-26.
24. Bonkovsky HL, Troy N, McNeal K, et al. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol 2002;37:848-54.
25. Erhardt A, Maschner-Olberg A, Mellenthin C, et al. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol 2003;38:335-42.
26. Beutler E, Felitti VJ, Koziol JA, et al. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-18.
27. Cohen AR, Galanello R, Pennell DJ, et al. Thalassemia. Hematology 2004:14-34.
28. Angelucci E, Muretto P, Nicolucci A, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002;100:17-21.
29. Borgna-Pignatti C, Vergine G, Lombardo T, et al. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 2004;124:114-17.
30. Silvestroni E, Bianco I. Screening for microcytemia in Italy: analysis of data collected in the past 30 years. Am J Hum Gen 1975;27:198-212.
31. Rund D, Rachmilewitz E. β-Thalassemia. New Engl J Med 2005;353:1135-46.
32. Papanikolaou G, Tzillianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood 2005;105:4103-5.
33. Weizer-Stern O, Adamsky K, Amariglio N, et al. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. Am J Hematol 2006;8:479-83.
34. Pippard MJ, Wainscoat JS. Erythrokinetics and iron status in heterozygous beta thalassaemia, and the effect of interaction with alpha thalassaemia. Br J Haematol 1987;66:123-7.
35. Rachmilewitz EA, Weizer-Stern O, Adamsky K, et al. Role of iron in inducing oxidative stress in thalassemia: can it be prevented by inhibition of absorption and by antioxidants? Ann NY Acad Sci 2005;1054:118-23.